{
  "trial_id": "NCT01092182",
  "overall_assessment": "likely_eligible",
  "inclusion": [
    {
      "criterion": "Burkitt Lymphoma",
      "label": "met",
      "evidence": "fluid analysis was consistent with Burkitt's lymphoma"
    },
    {
      "criterion": "Age greater than or equal to 18 years",
      "label": "met",
      "evidence": "44 year old female"
    },
    {
      "criterion": "Pathology confirmed by treating institution s Pathology Department",
      "label": "met",
      "evidence": "pericardial fluid was kappa light chain restricted CD10 positive monotypic B cells expressing FMC-7, CD19, CD20, and myc rearrangement consistent with Burkitt's Lymphoma"
    },
    {
      "criterion": "No prior treatment except patients may be entered if they have had prior limited-field radiotherapy",
      "label": "met",
      "evidence": "pericardiocentesis was performed"
    },
    {
      "criterion": "All disease stages",
      "label": "met",
      "evidence": "primary cardiac lymphoma"
    },
    {
      "criterion": "HIV negative or positive",
      "label": "met",
      "evidence": "no mention of HIV status"
    },
    {
      "criterion": "ECOG 0-4",
      "label": "unknown",
      "evidence": ""
    },
    {
      "criterion": "Ability of patient or durable power of attorney (DPA) for healthcare to give informed consent",
      "label": "met",
      "evidence": "patient presented with symptoms and was treated"
    },
    {
      "criterion": "Hepatitis B + patients may be enrolled at the discretion of the investigator",
      "label": "unknown",
      "evidence": ""
    }
  ],
  "exclusion": [
    {
      "criterion": "Patients with Primary CNS Lymphoma",
      "label": "not_met",
      "evidence": ""
    },
    {
      "criterion": "Inadequate renal function, defined as serum Cr > 1.5 or creatinine clearance < 50ml/min/1.73m2 unless lymphoma related",
      "label": "unknown",
      "evidence": ""
    },
    {
      "criterion": "Inadequate hepatic or hematological function: as follows, unless lymphoma-/disease-related",
      "label": "unknown",
      "evidence": ""
    },
    {
      "criterion": "The effects of EPOCH-R on the developing human fetus are unknown. For this reason and because chemotherapy agents are known to be teratogenic",
      "label": "not_met",
      "evidence": "female subject of child-bearing potential not willing to use an acceptable method of birth control"
    },
    {
      "criterion": "Female subject pregnant or breast-feeding",
      "label": "unknown",
      "evidence": ""
    },
    {
      "criterion": "History of a prior invasive malignancy in past 5 years",
      "label": "not_met",
      "evidence": "no mention of prior malignancy"
    }
  ],
  "notes": "",
  "_meta": {
    "topic_id": "4",
    "trial_id": "NCT01092182",
    "model": "llama3.1:8b",
    "run_tag": "llama31_8b_test10_top50"
  }
}